![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Co-Diagnostics Gains CE Mark for Zika Screening Test
Co-Diagnostics Gains CE Mark for Zika Screening Test
October 18, 2018
Co-Diagnostics received the CE Mark for its Logix Smart Zika screening test.
The polymerase chain reaction test can detect Zika’s presence in plasma collected from patients suspected to be infected.
Studies have linked Zika with cases of microcephaly, a neurological disease that affects the brain development of fetuses.
Upcoming Events
-
21Oct